Chinese Drug Developer Connect Biopharmaceuticals Completes $55 Million Series B Round
January 3, 2019 — 13:28 CST
This Data Is Locked!
This area is available only to Subscribers.
Connect Biopharmaceuticals, a clinical-stage biotech medicine developer, has completed a US$55 million series B round of financing, led by private equity Advantech Capital, according to... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals